Antibody Production Market Is Predicted To Grow Quickly Due To Increasing Focus Of Biopharmaceutical & Biotechnology Companies Till 2025: Grand View Research, Inc.
The global antibody production market is expected to reach a
value of USD 22.6 billion by 2025, according to a new report by Grand View
Research, Inc. Increasing demand for therapeutic antibodies including
monoclonal and polyclonal antibodies is a major factor that drives growth of
the market during forecast period. Antibodies are the dominant
biopharmaceuticals that specifically target the abnormal cells. Thus, many
pharmaceuticals and biotechnology companies have begun to focus on the
development of advanced antibodies for the treatment of chronic diseases such
as cancer, rheumatic heart disease, and arthritis.
Patent expiry of several
blockbuster monoclonal antibodies in the near future, is another major factor
supporting the growth of the antibody production market. Several antibodies
such as Avastin, Herceptin, and Mabthera are going to lose their patents in a
few years. For instance, the patent of Herceptin (trastuzumab) expired in
Europe in July 2014 and will expire in the U.S. in June 2019. Many companies
such as Amgen Inc., Synthon, Biocon, and Pfizer Inc. are developing biosimilar
for trastuzumab, which is expected to propel the demand for antibody production
products.
Browse full research report on Antibody Production Market: http://www.grandviewresearch.com/industry-analysis/antibody-production-market
Further key findings from
the study suggest:
- Downstream processing was the largest
revenue-grossing segment of the antibody production market in 2016. It is
also expected to exhibit the highest CAGR during the forecast period,
owing to large application of chromatography devices and resins in
downstream processing
- The monoclonal antibody segment was leading in 2016,
due to its higher demand in treatment of chronic diseases including
cancer, blood disorders, and growth hormone deficiency
- The pharmaceutical and biotechnology companies
segment dominated the overall market in terms of revenue in 2016, owing to
the large production of therapeutic antibodies and high investment in
R&D by companies for drug development
- North America was the largest revenue-generating
region of the market in the year 2016. This region is expected to maintain
its position during the forecast period because of the presence of several
leading biopharmaceuticals and biotechnology companies in this region
- Asia Pacific region is projected to be the
fastest-growing segment over the study period, due to rapidly booming
biotechnology industry and comparatively less stringent regulations for
biologics development in APAC region
- Some of the key players include GE Healthcare; Thermo
Fisher Scientific, Inc.; Sartorius AG; Merck KGaA; Pall Corp.; Eppendorf
AG; Cellab GmbH; INTEGRA Biosciences AG; and FiberCell Systems Inc.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the antibody production
market on the basis of type, process, end-use, and region:
Antibody Production Type Outlook (Revenue, USD Million;
2014 - 2025)
- Polyclonal
antibody
- Monoclonal
antibody
- Murine
- Chimeric
- Humanized
Antibody Production Process Outlook (Revenue, USD
Million; 2014 - 2025)
- Upstream
processing
- Bioreactors
- Largescale
bioreactors
- Single-use
bioreactors
- Consumables
- Media
- Buffers
and reagents
- Downstream
processing
- Chromatography
systems
- Chromatography
resins
- Filtration
- Filtration
systems
- Filtration
consumables and accessories
Antibody Production End-Use Outlook (Revenue, USD
Million; 2014 - 2025)
- Pharmaceutical
and biotechnology companies
- Research
laboratories
- Others
Antibody Production Regional Outlook (Revenue, USD
Million; 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- Japan
- China
- India
- Latin
America
- Brazil
- Mexico
- MEA
- South
Africa
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment